Skip to main content

News

All the latest news and information on the main advances in research, institutional milestones, teaching and management. Find out what happens at the Vall d'Hebron Research Institute!

The newly developed analytical workflow could in the future be introduced as a comprehensive diagnostic test for patients with mitochondrial diseases.

La 4º jornada del maneig integral del dolor busca agilitzar la transferència d’estudis preclínics a l’assistència per millorar la qualitat de vida dels pacients

El 48h Open House BCN 2022 torna un any més al Vall d’Hebron Barcelona Hospital Campus. Inscriu-te a l’esdeveniment i podràs gaudir de visites guiades pels diferents espais.

La Setmana de la Innovació arrenca dilluns amb cinc dies plens d’activitats relacionades amb la transformació digital, la simulació, la robòtica, l’emprenedoria i la recerca.

The donation allows to advance in the research of the mechanisms of primary immunodeficiencies and to evaluate the pathogenicity of mutations in patients.

Dr. Eva Colás' research has been one of the ten Biology and Biomedicine studies awarded with a Leonardo grant this 2022.

L’any passat es van presentar 41 fotografies per part de 20 autors a la categoria de Fotografia Científica i 37 fotografies de 20 autors a la de l’Hospital de les Persones.

The Interuniversity Research led by the NeuroPhar laboratory of the UPF has discovered that modulating the endocannabinoid system considerably improves some of the effects of the pathology.

Lesions present low levels of miR-885-5p, and this increases keratinocyte proliferation, the attraction of inflammatory cells and also the production of inflammatory mediators.

Understanding the changes that the fetus undergoes when exposed to cannabis will help to improve the prevention of consumption and the monitoring of pregnant cannabis users.

The presentations address the discovery of new drugs and therapeutic targets, clinical trial results and the improvement of clinical practice and patient experience.

The technique developed at Vall d'Hebron Research Institute (VHIR) uses a "switch" to block the reproduction of neuroblastoma cells

The international study has identified 89 genes involved in the risk of developing a stroke, 61 of which had not been previously described.

This is the first international study on the incidence of Mediterranean nutrition on the side effects of cancer treatments and survival of pediatric cancer patients.

La Societat Europea de Coloproctologia és una de les dues societats més rellevants a nivell internacional del seu sector.

El projecte pretén oferir un tractament precoç i localitzat en el moment de la teràpia de reperfusió per reduir significativament el dany del teixit i minimitzar l'aparició de complicacions cardíaques en el futur.

The VHIR and CEMCAT nurse has been recognized for his leadership of the Catalonia Expert Patient program in this disease.

On World Cancer Research Day, we highlight the impact of VHIR projects in the field of oncology.

The study, coordinated by Vall d'Hebron, aims to facilitate access to personalized medicine for all children and adolescents with cancer, regardless of where they live.

It is the project “New Nanotechnological Therapy for Parkinson’s disease: Nose to Brain Delivery of GBA-Polymer Nanoconjugates (nanoGBAtoBrain)”.

En les consultes de la Unitat de Tractament Integral de l’Obesitat de Vall d’Hebron els avenços de la recerca estan molt presents, ja sigui en forma d’assaig clínic o mitjançant la utilització d’unes ulleres de realitat virtual.

Entre els projectes es troben 12 investigacions on participen investigadors i investigadores de Vall d’Hebron.

Onze investigadors i investigadores de Vall d’Hebron faran xerrades i tallers amb l’objectiu d’apropar la ciència a tothom.

The paper has shown that those patients who are not able to normalize their microbiome after surgery have a worse prognosis.